Evidence map›Paper›PMID 27438224›Full record

ArticlePediatric research2016

Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy.

Jacob V Aranda, Charles L Cai, Taimur Ahmad, Vadim Bronshtein, Jonathan Sadeh, Gloria B Valencia, Douglas R Lazzaro, Kay D Beharry

Open access · hybridAbstract read
In one paragraph

Article in Pediatric research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Targeting adenosine APurinergic signalling · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Ocular Versus Oral Propranolol for Prevention and/or Treatment of Oxygen-Induced Retinopathy in a Rat Model.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Comparative Effects of Coenzyme Q10 orAntioxidants (Basel, Switzerland) · 2018
    Article
  15. Review
  16. Intermittent hypoxia suppression of growth hormone and insulin-like growth factor-I in the neonatal rat liver.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2018
    Article
  17. Adenosine AMolecular medicine (Cambridge, Mass.) · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jacob V ArandaDepartment of Pediatrics, State University of New York Downstate Medical Center, Brooklyn, New York.
Charles L CaiDepartment of Pediatrics, State University of New York Downstate Medical Center, Brooklyn, New York.
Taimur AhmadDepartment of Pediatrics, State University of New York Downstate Medical Center, Brooklyn, New York.
Vadim BronshteinDepartment of Pediatrics, State University of New York Downstate Medical Center, Brooklyn, New York.
Jonathan SadehDepartment of Pediatrics, State University of New York Downstate Medical Center, Brooklyn, New York.
Gloria B ValenciaDepartment of Pediatrics, State University of New York Downstate Medical Center, Brooklyn, New York.
Douglas R LazzaroDepartment of Ophthalmology, State University of New York Downstate Medical Center, Brooklyn, New York.
Kay D BeharryDepartment of Pediatrics, State University of New York Downstate Medical Center, Brooklyn, New York.
State University of New York · USSUNY Downstate Health Sciences University · USEye Cancer Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCaffeine or ketorolac decrease the risk of retinopathy of prematurity and may act synergistically to improve beneficial effect. Combination of caffeine (Caff) and ketorolac (Keto) to prevent oxygen-induced retinopathy was studied.

methodsNewborn rats exposed to room air (RA) or intermittent hypoxia (IH) consisting of 12% O2 during hyperoxia (50% O2) from birth (P0) had single daily IP injections of Caff from P0-P13 or saline; and/or ocular Keto (Acuvail, 0.45% ophthalmic solution) administered subcutaneously over the eyes from P5-P7. Pups were studied at P14 or placed in RA for recovery from IH (IHR) until P21. Eyes were examined for neovascularization, histopathology, growth factors, and VEGF-signaling genes.

resultsSevere retinal damage noted during IHR in the untreated groups evidenced by hemorrhage, neovascularization, and oxygen-induced retinopathy (OIR) pathologies were prevented with Keto/Caff treatment. Keto and/or Caff treatment in IH also promoted retinal neural development evidenced by eye opening (92%, P < 0.001 vs. 31% in the placebo-treated IH group). No corneal pathologies were noted with Keto.

conclusionCaff or Keto given individually reduced retinal neovascularization, but the two drugs given together prevented severe OIR.

Indexed as

AnimalsAnimals, NewbornAnti-Inflammatory Agents, Non-SteroidalApyraseArteriesBody WeightCaffeineCentral Nervous System StimulantsChoroidCitratesDinoprostDrug SynergismFemaleHemorrhageHypoxia-Inducible Factor 1, alpha SubunitInsulin-Like Growth Factor I8-epi-prostaglandin F2alphaAnti-Inflammatory Agents, Non-SteroidalApyraseCaffeinecaffeine citrateCentral Nervous System StimulantsCitratesDinoprostHif1a protein, ratHypoxia-Inducible Factor 1, alpha Subunitinsulin-like growth factor-1, ratInsulin-Like Growth Factor IIntercellular Signaling Peptides and ProteinsKetorolacOxygenVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1

Identifiers

PMID27438224
PMCPMC5030702
OpenAlexW2481431181

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.